A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT07046780 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor Cancer
Metastatic Solid Tumors
Locally Advanced

Interventions

DRUG: Observation arm

Sponsor

PENG YUAN